Related Experiment Video
Updated: Oct 11, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Pharmacological Treatment Options for Coronavirus Disease-19 in Renal Patients
Jonny1, Laurencia Violetta1, Arief Sjamsulaksan Kartasasmita2
1Nephrology Division, Department of Internal Medicine, Gatot Soebroto Indonesia Army Central Hospital, Jakarta, Indonesia.
Insights
Patients with chronic kidney disease (CKD) need specific COVID-19 drug guidance. This review details necessary dosage adjustments and renal side effects for managing SARS-CoV-2 in kidney patients.
Area of Science:
- Nephrology
- Infectious Diseases
- Pharmacology
Background:
- Patients with chronic kidney disease (CKD) face increased risk from SARS-CoV-2 infection.
- Existing comorbidities in CKD patients exacerbate COVID-19 severity.
- No specific guidelines exist for managing COVID-19 in renal impairment.
Purpose of the Study:
- To review dosing adjustments for COVID-19 drugs in patients with kidney dysfunction.
- To identify potential renal side effects of common COVID-19 treatments.
- To inform nephrologists on optimizing SARS-CoV-2 management in CKD.
Main Methods:
- Non-systematic review of COVID-19 treatments.
- Exploration of clinical trial databases and search engines.
- Analysis of drug information for renal dosing and side effects.
Main Results:
- Several antivirals and monoclonal antibodies require dosage modification for kidney dysfunction.
- Monitoring for renal side effects is crucial with combined drug therapies.
- Optimal therapeutic effects depend on careful dose titration based on renal function.
Conclusions:
- Nephrologists must carefully adjust COVID-19 drug dosages based on renal function.
- Close monitoring for renal side effects is essential to prevent further kidney damage.
- Further research is needed to establish safety and efficacy in renal patients.
Abstract:
Patients with chronic kidney disease (CKD), including dialysis and transplant patients, are at greater risk of contracting SARS-CoV-2 due to kidney dysfunction and preexisting comorbidities. To date, a specific guideline on managing these high-risk patients infected with COVID-19 has not been established. As the current management of COVID-19 comprises mainly experimental drugs, the authors aim to provide information on dosing adjustments at different stages of kidney dysfunction and notable renal side effects. We performed a nonsystematical review of currently available COVID-19 drugs exploring several different clinical trial databases and search browsers. Several antivirals and monoclonal antibodies used in COVID-19 treatment require dosage adjustments in kidney dysfunction. In a global pandemic setting, nephrologists need to consider the appropriate dosage according to the renal function and closely monitor the side effects of different drug combinations to obtain the optimum therapeutic effect while avoiding further renal damage. Further studies are required to determine the safety and efficacy of these drugs in renal patients.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Heart Failure V: Medical Management
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care

